• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-92a 家族及其在肿瘤发生和转移中的靶基因。

miR-92a family and their target genes in tumorigenesis and metastasis.

机构信息

Department of Pathophysiology, Basic Medical Science of Dalian Medical University, Dalian 116044, China; Institute of Cancer Stem Cell, Dalian Medical University Cancer Center, Dalian 116044, China.

Department of Pathophysiology, Basic Medical Science of Dalian Medical University, Dalian 116044, China.

出版信息

Exp Cell Res. 2014 Apr 15;323(1):1-6. doi: 10.1016/j.yexcr.2013.12.025. Epub 2014 Jan 4.

DOI:10.1016/j.yexcr.2013.12.025
PMID:24394541
Abstract

The miR-92a family, including miR-25, miR-92a-1, miR-92a-2 and miR-363, arises from three different paralog clusters miR-17-92, miR-106a-363, and miR-106b-25 that are highly conservative in the process of evolution, and it was thought as a group of microRNAs (miRNAs) correlated with endothelial cells. Aberrant expression of miR-92a family was detected in multiple cancers, and the disturbance of miR-92a family was related with tumorigenesis and tumor development. In this review, the progress on the relationship between miR-92a family and their target genes and malignant tumors will be summarized.

摘要

miR-92a 家族,包括 miR-25、miR-92a-1、miR-92a-2 和 miR-363,来自三个不同的基因簇 miR-17-92、miR-106a-363 和 miR-106b-25,这些基因簇在进化过程中高度保守,被认为是一组与内皮细胞相关的 microRNAs(miRNAs)。miR-92a 家族的异常表达在多种癌症中被检测到,miR-92a 家族的紊乱与肿瘤发生和肿瘤发展有关。本综述总结了 miR-92a 家族及其靶基因与恶性肿瘤之间关系的研究进展。

相似文献

1
miR-92a family and their target genes in tumorigenesis and metastasis.miR-92a 家族及其在肿瘤发生和转移中的靶基因。
Exp Cell Res. 2014 Apr 15;323(1):1-6. doi: 10.1016/j.yexcr.2013.12.025. Epub 2014 Jan 4.
2
MiR-92a modulates proliferation, apoptosis, migration, and invasion of osteosarcoma cell lines by targeting Dickkopf-related protein 3.miR-92a 通过靶向 Dickkopf 相关蛋白 3 调节骨肉瘤细胞系的增殖、凋亡、迁移和侵袭。
Biosci Rep. 2019 Apr 26;39(4). doi: 10.1042/BSR20190410. Print 2019 Apr 30.
3
MiR-218 mediates tumorigenesis and metastasis: Perspectives and implications.微小RNA-218介导肿瘤发生与转移:观点与启示
Exp Cell Res. 2015 May 15;334(1):173-82. doi: 10.1016/j.yexcr.2015.03.027. Epub 2015 Apr 7.
4
Prominent roles of microRNA-142 in cancer.miR-142 在癌症中的重要作用
Pathol Res Pract. 2020 Nov;216(11):153220. doi: 10.1016/j.prp.2020.153220. Epub 2020 Sep 22.
5
Cell type-dependent functions of microRNA-92a.microRNA-92a 的细胞类型依赖性功能。
J Cell Biochem. 2018 Jul;119(7):5798-5804. doi: 10.1002/jcb.26765. Epub 2018 Mar 25.
6
The other face of miR-17-92a cluster, exhibiting tumor suppressor effects in prostate cancer.miR-17-92a簇的另一面,在前列腺癌中表现出肿瘤抑制作用。
Oncotarget. 2016 Nov 8;7(45):73739-73753. doi: 10.18632/oncotarget.12061.
7
MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.微小 RNA-92a 通过激活 PTEN/PI3K/AKT 信号通路促进非小细胞肺癌转移中的上皮-间充质转化。
Int J Oncol. 2017 Jul;51(1):235-244. doi: 10.3892/ijo.2017.3999. Epub 2017 May 16.
8
MiR-106a: Promising biomarker for cancer.微小RNA-106a:颇具前景的癌症生物标志物。
Bioorg Med Chem Lett. 2016 Nov 15;26(22):5373-5377. doi: 10.1016/j.bmcl.2016.10.042. Epub 2016 Oct 15.
9
MiR-92a regulates oral squamous cell carcinoma (OSCC) cell growth by targeting FOXP1 expression.miR-92a 通过靶向 FOXP1 表达调控口腔鳞状细胞癌(OSCC)细胞生长。
Biomed Pharmacother. 2018 Aug;104:77-86. doi: 10.1016/j.biopha.2018.05.025. Epub 2018 May 14.
10
MiR-92a promotes tumorigenesis of colorectal cancer, a transcriptomic and functional based study.miR-92a 促进结直肠癌的肿瘤发生:基于转录组和功能的研究。
Biomed Pharmacother. 2018 Oct;106:1370-1377. doi: 10.1016/j.biopha.2018.07.098. Epub 2018 Jul 23.

引用本文的文献

1
Genomic analyses of intricate interaction of TE-lncRNA overlapping genes with miRNAs in human diseases.人类疾病中 TE-lncRNA 重叠基因与 miRNAs 复杂相互作用的基因组分析。
Genes Genomics. 2024 Nov;46(11):1313-1325. doi: 10.1007/s13258-024-01547-1. Epub 2024 Aug 31.
2
The role and mechanism of action of miR‑92a in endothelial cell autophagy.miR-92a 在血管内皮细胞自噬中的作用和机制。
Mol Med Rep. 2024 Sep;30(3). doi: 10.3892/mmr.2024.13296. Epub 2024 Jul 26.
3
HNRNPA2B1-Mediated MicroRNA-92a Upregulation and Section Acts as a Promising Noninvasive Diagnostic Biomarker in Colorectal Cancer.
HNRNPA2B1介导的微小RNA-92a上调及剪切在结直肠癌中作为一种有前景的非侵入性诊断生物标志物。
Cancers (Basel). 2023 Feb 21;15(4):1367. doi: 10.3390/cancers15051367.
4
MicroRNA-92a-3p Inhibits Cell Proliferation and Invasion by Regulating the Transcription Factor 21/Steroidogenic Factor 1 Axis in Endometriosis.微小 RNA-92a-3p 通过调控转录因子 21/类固醇生成因子 1 轴抑制子宫内膜异位症中的细胞增殖和侵袭。
Reprod Sci. 2023 Jul;30(7):2188-2197. doi: 10.1007/s43032-021-00734-9. Epub 2023 Jan 17.
5
MicroRNAs in Cancer and Cardiovascular Disease.微小 RNA 在癌症和心血管疾病中的作用。
Cells. 2022 Nov 10;11(22):3551. doi: 10.3390/cells11223551.
6
Exosomal miR92a Promotes Cytarabine Resistance in Myelodysplastic Syndromes by Activating Wnt/β-catenin Signal Pathway.外泌体 miR92a 通过激活 Wnt/β-catenin 信号通路促进骨髓增生异常综合征中阿糖胞苷耐药。
Biomolecules. 2022 Oct 9;12(10):1448. doi: 10.3390/biom12101448.
7
A regulatory network comprising let-7 miRNA and SMUG1 is associated with good prognosis in ER+ breast tumours.一个包含 let-7 miRNA 和 SMUG1 的调控网络与 ER+ 乳腺癌的良好预后相关。
Nucleic Acids Res. 2022 Oct 14;50(18):10449-10468. doi: 10.1093/nar/gkac807.
8
Immunomodulatory Properties of Human Breast Milk: MicroRNA Contents and Potential Epigenetic Effects.人乳的免疫调节特性:微小RNA含量及潜在的表观遗传效应
Biomedicines. 2022 May 24;10(6):1219. doi: 10.3390/biomedicines10061219.
9
Expression of specific microRNAs in tissue and plasma in colorectal cancer.结直肠癌组织及血浆中特定微小RNA的表达
J Pathol Transl Med. 2023 May;57(3):147-157. doi: 10.4132/jptm.2022.02.19. Epub 2022 May 3.
10
Evaluation of microRNA 92a Expression and Its Target Protein Bim in Colorectal Cancer.评估结直肠癌中 microRNA-92a 的表达及其靶蛋白 Bim。
Asian Pac J Cancer Prev. 2022 Feb 1;23(2):723-730. doi: 10.31557/APJCP.2022.23.2.723.